Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 3/2009

01-12-2009 | Section introduction

Are current drug development programmes realising the full potential of new agents? Introduction to Sessions 7 and 8

Author: Stephen RD Johnston

Published in: Breast Cancer Research | Special Issue 3/2009

Login to get access

Excerpt

The final two sessions of the meeting addressed the question of whether current drug development programmes for new agents in breast cancer are realising their full potential. …
Metadata
Title
Are current drug development programmes realising the full potential of new agents? Introduction to Sessions 7 and 8
Author
Stephen RD Johnston
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 3/2009
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2439

Other articles of this Special Issue 3/2009

Breast Cancer Research 3/2009 Go to the issue

Short communication

Underarm antiperspirants/deodorants and breast cancer

Short communication

Breast tumour stroma is a prognostic indicator and target for therapy

Section introduction

Who would have thought it! Influence on outcome of radiotherapy, Ki67 and stroma. Introduction to Session 5

Short communication

Alcohol consumption and breast cancer risk

Short communication

Who would have thought a single Ki67 measurement would predict long-term outcome?

Introduction

Controversies in Breast Cancer 2009
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits